{"id":641334,"date":"2017-09-19T04:05:45","date_gmt":"2017-09-19T04:05:45","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/"},"modified":"2017-09-19T04:05:45","modified_gmt":"2017-09-19T04:05:45","slug":"ibnsina-pharma-files-intention-to-float-on-egx","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/","title":{"rendered":"Ibnsina Pharma files intention to float on EGX"},"content":{"rendered":"

<\/a> IPO WATCH- Ibnsina Pharma<\/strong> announced its intention to proceed with an initial public offering (pdf)<\/a> on the EGX. The company, Egypt\u2019s fastest-growing pharma distributor, is offering around 25% of its shares through both primary and secondary offerings. (You can check out its corporate website here<\/a>.)The transaction will take place in 4Q2017 or 1Q2018 and Ibnsina will use the proceeds of the transaction to grow its \u201ccore distribution business and support its expansion into new, higher-margin revenue streams.\u201d Chairman Mohsen Mahgoub says, \u201cToday, we are Egypt\u2019s fastest-growing and second largest pharmaceutical distributor serving around 34,000 clients including retail pharmacies, hospitals and public health units across Egypt with products from over 300 local and multinational pharmaceutical companies.\u201d The European Bank for Reconstruction and Development (EBRD) owns a 21% stake in company and Mahgoub says \u201cthe presence of institutional shareholders such as EBRD and Faisal Islamic Bank has allowed us to significantly enhance our corporate governance practices and systems ahead of our intended listing on the Egyptian Exchange.\u201d Ibnsina Pharma shareholders include the Mahgoub family (24%), the Abdel Gawad family (23%), EBRD (21%), and Faisal Islamic Bank (16%). Other shareholders, including members of the senior management team, collectively hold the remaining 16%.<\/p>\n

Beltone Investment Banking<\/strong> is acting as sole global coordinator and bookrunner on the transaction, while Matouk Bassiouny<\/strong> is acting as legal counsel to the issuer.<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO WATCH- Ibnsina Pharma announced its intention to proceed with an initial public offering (pdf) on the EGX. The company, Egypt\u2019s fastest-growing pharma distributor, is offering around 25% of its shares through both primary and secondary offerings. (You can check out its corporate website here.)The transaction will take place in 4Q2017 or 1Q2018 and Ibnsina […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-641334","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"7fd98ea2-e81f-469b-81a5-5aa3ba68820b","order":"0","is_powered_by":true,"section_story_id":"01c25098-ce79-461b-98d0-7efdce918e7d","story_type":"1","photo_url":"","photo_position":"above","related_issue":[641325],"teaser":"","voice_url":""},"yoast_head":"\nIbnsina Pharma files intention to float on EGX - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ibnsina Pharma files intention to float on EGX\" \/>\n<meta property=\"og:description\" content=\"IPO WATCH- Ibnsina Pharma announced its intention to proceed with an initial public offering (pdf) on the EGX. The company, Egypt\u2019s fastest-growing pharma distributor, is offering around 25% of its shares through both primary and secondary offerings. (You can check out its corporate website here.)The transaction will take place in 4Q2017 or 1Q2018 and Ibnsina […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-19T04:05:45+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Ibnsina Pharma files intention to float on EGX\",\"datePublished\":\"2017-09-19T04:05:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/\"},\"wordCount\":226,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"EnterpriseAM\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/\",\"name\":\"Ibnsina Pharma files intention to float on EGX - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2017-09-19T04:05:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ibnsina Pharma files intention to float on EGX\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ibnsina Pharma files intention to float on EGX - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/","og_locale":"en_US","og_type":"article","og_title":"Ibnsina Pharma files intention to float on EGX","og_description":"IPO WATCH- Ibnsina Pharma announced its intention to proceed with an initial public offering (pdf) on the EGX. The company, Egypt\u2019s fastest-growing pharma distributor, is offering around 25% of its shares through both primary and secondary offerings. (You can check out its corporate website here.)The transaction will take place in 4Q2017 or 1Q2018 and Ibnsina […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2017-09-19T04:05:45+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Ibnsina Pharma files intention to float on EGX","datePublished":"2017-09-19T04:05:45+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/"},"wordCount":226,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["EnterpriseAM","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/","url":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/","name":"Ibnsina Pharma files intention to float on EGX - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2017-09-19T04:05:45+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/09\/19\/ibnsina-pharma-files-intention-to-float-on-egx\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Ibnsina Pharma files intention to float on EGX"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":639532,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/10\/31\/ibnsina-submits-ipo-paperwork-to-the-egx\/","url_meta":{"origin":641334,"position":0},"title":"Ibnsina submits IPO paperwork to the EGX","author":"enterpriseam admin","date":"31 October 2017","format":false,"excerpt":"IPO WATCH- Ibnsina Pharma has submitted paperwork to the bourse to begin procedures for its initial public offering, according to a disclosure. The company is looking to offer 25% of its shares on the EGX before the end of 4Q2017, Al Mal says. Ibnsina had tapped Beltone Financial back in\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":635676,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/12\/11\/ibnsina-pharma-to-begin-trading-on-egx-tomorrow-as-isph-ca-retail-offering-18-35x-oversubscribed\/","url_meta":{"origin":641334,"position":1},"title":"Ibnsina Pharma to begin trading on EGX tomorrow as ISPH.CA, retail offering 18.35x oversubscribed","author":"enterpriseam admin","date":"11 December 2017","format":false,"excerpt":"IPO WATCH- Ibnsina Pharma retail offering closes, trading to start tomorrow: Shares Ibnsina Pharma, Egypt\u2019s fastest-growing and second-largest distributor of pharmaceutical products, will begin trading on the EGX on Tuesday after the book-building process for its retail offering ended yesterday. The company\u2019s shares will trade under the stock symbol ISPH.CA\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":599894,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/","url_meta":{"origin":641334,"position":2},"title":"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt","author":"enterpriseam admin","date":"14 January 2019","format":false,"excerpt":"Ibnsina to distribute Novartis\u2019 Alcon products in Egypt: Ibnsina Pharma will distribute global eye care product manufacturer Novartis\u2019 Alcon\u2019s products in Egypt, according to a company statement (pdf). The newly inked agreement lends further credence to the argument \u201cthat exclusivity is dying in the pharma market,\u201d Ibnsina Co-CEO Omar Abdel\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":637165,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/11\/09\/ibnsina-gets-egx-nod-to-list-shares-plans-november-transaction-roadshow\/","url_meta":{"origin":641334,"position":3},"title":"Ibnsina gets EGX nod to list shares, plans November transaction roadshow","author":"enterpriseam admin","date":"9 November 2017","format":false,"excerpt":"IPO WATCH- Ibnsina has listed its shares on the Egyptian Exchange (EGX) ahead of itsplanned initial public offering of c. 37.5% of its total share capital via a primary offering of newly issued shares and a secondary offering of existing shares held by current shareholders, the company said in a\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":635466,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/12\/05\/ibnsina-pharma-prices-ipo-at-egp-5-80-per-share-says-institutional-offering-is-more-than-17x-oversubscribed\/","url_meta":{"origin":641334,"position":4},"title":"Ibnsina Pharma prices IPO at EGP 5.80 per share, says institutional offering is more than 17x oversubscribed","author":"enterpriseam admin","date":"5 December 2017","format":false,"excerpt":"IPO WATCH- Ibnsina Pharma prices IPO at EGP 5.80 per share, says institutional offering is more than 17x oversubscribed: Ibnsina Pharma announced this morning that it has concluded the book-building process and pricing of its institutional offering of c. 229 mn shares as part of its IPO on the Egyptian\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":600746,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/02\/10\/efg-hermes-ibnsina-pharma-poised-to-capitalize-on-rising-demand\/","url_meta":{"origin":641334,"position":5},"title":"EFG Hermes: Ibnsina Pharma poised to \u201ccapitalize on rising demand\u201d","author":"enterpriseam admin","date":"10 February 2019","format":false,"excerpt":"Ibnsina Pharma poised to \u201ccapitalize on rising demand\u201d -EFG Hermes: Leading frontier and emerging markets investment bank EFG Hermes has initiated coverage on IbnsinaPharma, which it characterizes as \u201cwell-positioned to capture Egypt\u2019s rising \u2026 demand and continue outperforming the market.\u201d EFG Hermes has a \u201cBuy\u201d on Ibnsina with a target\u2026","rel":"","context":"In "Speed Round"","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/641334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=641334"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/641334\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/641325"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=641334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=641334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=641334"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=641334"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=641334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}